HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

FDA pushes back deadlines for compliance with its final rule for sunscreen labeling and effectiveness testing, giving manufacturers an additional six months for products with annual sales of at least $25,000. More news in brief.

Advertisement

Related Content

Cosmetic User Fees, FDA Warnings, California: Top “Rose Sheet” Topics Of 2012
PCPC’s “Skin Smart” Videos Promote Sunscreen Importance, Daily Use
Merck Settles Class Suit Targeting Coppertone Claims, Denies Wrongdoing
Merck Faces Consumer Suit Over Coppertone UV Claims
Merck Faces Consumer Suit Over Coppertone UV Claims
Children’s Sunscreens Boost EWG Recommendation Rate In 2012
In Brief
P&G Promises Greater Innovation In Personal Care After Lackluster Q3
Industry Needs More Time To Comply With Sunscreen Testing, Labeling Rule
Gillette, Energizer Cross Razors Again With NAD Challenges

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS018092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel